These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18294095)

  • 1. Hyperthermia and rhabdomyolysis in an adolescent treated with topiramate and olanzapine.
    Strawn JR; Adler CM; Strakowski SM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):116-8. PubMed ID: 18294095
    [No Abstract]   [Full Text] [Related]  

  • 2. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
    J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate and hepatotoxicity.
    Doan RJ; Clendenning M
    Can J Psychiatry; 2000 Dec; 45(10):937-8. PubMed ID: 11190367
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible priapism during olanzapine and lithium therapy.
    Jagadheesan K; Thakur A; Akhtar S
    Aust N Z J Psychiatry; 2004 May; 38(5):381. PubMed ID: 15144518
    [No Abstract]   [Full Text] [Related]  

  • 8. Topiramate leukopenia on clozapine.
    Behar D; Schaller JL
    Eur Child Adolesc Psychiatry; 2004 Feb; 13(1):51-2. PubMed ID: 14991432
    [No Abstract]   [Full Text] [Related]  

  • 9. Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia.
    Ziad el K; Rahi AC; Hamdan SA; Mikati MA
    Neurology; 2005 Oct; 65(7):1139-40. PubMed ID: 16217081
    [No Abstract]   [Full Text] [Related]  

  • 10. Topiramate for refractory schizophrenia.
    Millson RC; Owen JA; Lorberg GW; Tackaberry L
    Am J Psychiatry; 2002 Apr; 159(4):675. PubMed ID: 11925318
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute dystonia with intramuscular olanzapine in adolescent mania: a report.
    Goyal N; Thakur A; Sinha VK
    Aust N Z J Psychiatry; 2005; 39(11-12):1046-7. PubMed ID: 16343308
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders.
    Barzman DH; DelBello MP; Kowatch RA; Warner J; Rofey D; Stanford K; Rappaport K; Daniels JP; Strakowski SM
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):931-7. PubMed ID: 16379513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate-induced depression.
    Klufas A; Thompson D
    Am J Psychiatry; 2001 Oct; 158(10):1736. PubMed ID: 11579016
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
    Tavakoli SA; Arguisola MS
    South Med J; 2003 Jul; 96(7):729-30. PubMed ID: 12940340
    [No Abstract]   [Full Text] [Related]  

  • 16. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder.
    Chiu YH; Chen CH; Shen WW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):581-2. PubMed ID: 18006134
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced acute rhabdomyolysis-a case report.
    Baumgart U; Schmid R; Spiessl H
    Pharmacopsychiatry; 2005 Jan; 38(1):36-7. PubMed ID: 15706465
    [No Abstract]   [Full Text] [Related]  

  • 18. Panic attacks associated with topiramate.
    Damsa C; Warczyk S; Cailhol L; Kelley-Puskas AM; Cicotti A; Lazignac C; Andreoli A
    J Clin Psychiatry; 2006 Feb; 67(2):326-7. PubMed ID: 16566634
    [No Abstract]   [Full Text] [Related]  

  • 19. Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder.
    Andrade C
    Bipolar Disord; 2001 Aug; 3(4):211-2. PubMed ID: 11552960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.
    Su KP; Lane HY; Chuang CL; Chen KP; Shen WW
    Schizophr Res; 2004 Feb; 66(2-3):191-2. PubMed ID: 15061254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.